SCHEDULE 13D

Company

NRX Pharmaceuticals, Inc.

Filed

November 26, 2018

Accession Number

0001213900-18-016512

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →